Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 14517528.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prednisolone has unknown growth-suppressing effects relative to other steroids. We retrospectively studied 9 children (6 with congenital adrenal hyperplasia, CAH) receiving hydrocortisone replacement after switching to prednisolone (dose ratio, 1:5). Growth velocity and, in patients with CAH, 17-OHP decreased significantly. Dose reduction reversed these effects. Roughly, growth suppression relative potency for prednisolone:hydrocortisone was 15:1.
Medical subject headings
- Adrenal Hyperplasia, Congenital
- Adrenal Insufficiency
- Anti-Inflammatory Agents
- Growth Disorders
- Hydrocortisone
- Prednisolone